[USA] Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3 (글루타레독신 3의 발현 수준에 기초가 된 폐암과 직장결장암의 진단 또는 예후)

출원번호(Application number) : 13259918 (2009.04.15)

등록번호(Registration number) : 09128095 (2015.09.08)

특허권자(Patentee) : Paichai University Industry-Academic Cooperation Foundation

요약(Summary) :

The present invention relates to a biomarker for diagnosing lung cancer and colorectal cancer containing glutaredoxin 3 as an active ingredient, and a kit for diagnosing lung cancer and colorectal cancer using the same biomarker. Glutaredoxin 3 of the present invention is over-expressed in lung cancer tissue and colorectal cancer tissue, which enables early prediction of diagnosis or prognosis of lung cancer and colorectal cancer. Thus, glutaredoxin 3 can be helpfully used as a biomarker for diagnosing lung cancer and colorectal cancer.

If you have any questions or if you are interested in buying/selling this patent, please contact us at the email address kiyul@kiyul.co.kr